225 related articles for article (PubMed ID: 25861653)
1. IFN-CSP inhibiting hepatitis B virus in HepG2.2.15 cells involves JAK-STAT signal pathway.
Lu X; Wang J; Jin X; Huang Y; Zeng W; Zhu J
Biomed Res Int; 2015; 2015():959684. PubMed ID: 25861653
[TBL] [Abstract][Full Text] [Related]
2. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK/STAT signal pathway.
Wang T; Wang X; Zhuo Y; Si C; Yang L; Meng L; Zhu B
J Ethnopharmacol; 2020 Jul; 257():112782. PubMed ID: 32217096
[TBL] [Abstract][Full Text] [Related]
4. Anti-hepatitis B virus activity and mechanisms of recombinant human serum albumin-interferon-alpha-2b fusion protein in vitro and in vivo.
Bingfa X; Qinglin F; Hui H; Canjun W; Wei W; Lihua S
Pharmacology; 2009; 83(6):323-32. PubMed ID: 19407486
[TBL] [Abstract][Full Text] [Related]
5. [The influence of HBV and its antigens on the expressions of JAK-STAT signal transduction pathway molecules and antiviral proteins of IFN alpha].
Guan SH; Yang K; Lu MJ; Lu YP; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):440-4. PubMed ID: 22053375
[TBL] [Abstract][Full Text] [Related]
6. IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2
Xu S; Huang J; Xun Z; Li S; Fu Y; Lin N; Wu W; Chen T; Liu C; Ou Q
Microbiol Spectr; 2022 Dec; 10(6):e0155722. PubMed ID: 36314949
[TBL] [Abstract][Full Text] [Related]
7. Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling.
Li L; Lei QS; Zhang SJ; Kong LN; Qin B
PLoS One; 2016; 11(5):e0156496. PubMed ID: 27227879
[TBL] [Abstract][Full Text] [Related]
8. IFNA2 p.Ala120Thr impairs the inhibitory activity of Interferon-α2 against the hepatitis B virus through altering its binding to the receptor.
Chen C; Zhu X; Xu W; Yang F; Zhang G; Wu L; Zheng Y; Gao Z; Xie C; Peng L
Antiviral Res; 2017 Nov; 147():11-18. PubMed ID: 28958921
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells.
Zhang J; Liu K; Zhang G; Ling N; Chen M
Virol J; 2022 Feb; 19(1):28. PubMed ID: 35144643
[TBL] [Abstract][Full Text] [Related]
10. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
[TBL] [Abstract][Full Text] [Related]
12. High-level expression of a novel liver-targeting fusion interferon with preferred Escherichia coli codon preference and its anti-hepatitis B virus activity in vivo.
Lu X; Wang J; Jin X; Zhu J
BMC Biotechnol; 2015 Jun; 15():54. PubMed ID: 26063245
[TBL] [Abstract][Full Text] [Related]
13. Silencing SIRT1 promotes the anti-HBV action of IFN-α by regulating Pol expression and activating the JAK-STAT signaling pathway.
Tang Q; Meng C; Liu Y; Cheng Y; Liu Y; Long Y; Sun S; Feng F
Int Immunopharmacol; 2023 Nov; 124(Pt B):110939. PubMed ID: 37741128
[TBL] [Abstract][Full Text] [Related]
14. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro.
Zhang H; Guan ZS; Guan SH; Yang K; Pan Y; Wu YY; Wang AH; Sun BB; Hou J; Mu XX; Gao YF; Cheng WS
Clin Lab; 2016 Dec; 62(12):2313-2318. PubMed ID: 28164560
[TBL] [Abstract][Full Text] [Related]
15. [ISGF3, a critical factor of the IFN-alpha pathway in the antiviral action of HBV].
Zhang Q; Wei L; Wang Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):110-3. PubMed ID: 16027772
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha induces high expression of APOBEC3G and STAT-1 in vitro and in vivo.
Chen H; Wang LW; Huang YQ; Gong ZJ
Int J Mol Sci; 2010 Sep; 11(9):3501-12. PubMed ID: 20957108
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus polymerase impairs interferon-α-induced STA T activation through inhibition of importin-α5 and protein kinase C-δ.
Chen J; Wu M; Zhang X; Zhang W; Zhang Z; Chen L; He J; Zheng Y; Chen C; Wang F; Hu Y; Zhou X; Wang C; Xu Y; Lu M; Yuan Z
Hepatology; 2013 Feb; 57(2):470-82. PubMed ID: 22996189
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to Interferon alpha.
Li J; Chen F; Zheng M; Zhu H; Zhao D; Liu W; Liu W; Chen Z
Antiviral Res; 2010 Mar; 85(3):463-9. PubMed ID: 19857525
[TBL] [Abstract][Full Text] [Related]
19. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes.
Hou ZH; Han QJ; Zhang C; Tian ZG; Zhang J
Liver Int; 2014 Jan; 34(1):58-68. PubMed ID: 23890093
[TBL] [Abstract][Full Text] [Related]
20. TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK-STAT signaling pathway.
Zhu X; Xie C; Li YM; Huang ZL; Zhao QY; Hu ZX; Wang PP; Gu YR; Gao ZL; Peng L
Cell Death Dis; 2016 Jun; 7(6):e2239. PubMed ID: 27253403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]